Safety and Efficacy of Fingolimod in Japanese Patients with Multiple Sclerosis: Interim Analysis Results from Post-marketing Surveillance

被引：0
|
作者：
Kira, J. [1 ]
Fujihara, K. [2 ]
Ueda, K. [3 ]
Tajima, T. [4 ]
Ueno, M. [4 ]
Saida, T. [5 ,6 ,7 ]
机构：
[1] Kyushu Univ, Inst Neurol, Grad Sch Med Sci, Fukuoka 812, Japan
[2] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan
[3] Novartis Pharma KK, Tokyo, Japan
[4] Mitsubishi Tanabe Pharma Corp, Osaka, Japan
[5] Kyoto Min Iren Cent Hosp, Kyoto, Japan
[6] Inst Neurotherapeut, Kyoto, Japan
[7] Kyoto Univ Hosp, Kyoto 606, Japan
来源：
MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-55
引用
收藏
页码：928 / 928
页数：1
相关论文
共 50 条
  • [1] Safety and effectiveness of eculizumab in Japanese patients with generalized myasthenia gravis: interim analysis of post-marketing surveillance
    Murai, Hiroyuki
    Suzuki, Shigeaki
    Hasebe, Miki
    Fukamizu, Yuji
    Rodrigues, Ema
    Utsugisawa, Kimiaki
    [J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
  • [2] Safety and effectiveness of empagliflozin in Japanese patients with type 2 diabetes: interim analysis from a post-marketing surveillance study
    Kaku, Kohei
    Chin, Rina
    Naito, Yusuke
    Iliev, Hristo
    Ikeda, Rie
    Ochiai, Kaori
    Yasui, Atsutaka
    [J]. EXPERT OPINION ON DRUG SAFETY, 2020, 19 (02) : 211 - 221
  • [3] POST-MARKETING SURVEILLANCE OF TOFACITINIB IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS: AN INTERIM REPORT OF SAFETY DATA
    Tamura, N.
    Kuwana, M.
    Atsumi, T.
    Takei, S.
    Harigai, M.
    Fujii, T.
    Matsuno, H.
    Mimori, T.
    Momohara, S.
    Yamamoto, K.
    Nomura, K.
    Endo, Y.
    Sugiyama, N.
    Hirose, T.
    Morishima, Y.
    Yoshii, N.
    Takagi, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1408 - 1408
  • [4] Post-Marketing Surveillance of Tofacitinib in Japanese Patients with Rheumatoid Arthritis: An Interim Report of Safety Data
    Mimori, Tsuneyo
    Harigai, Masayoshi
    Atsumi, Tatsuya
    Kuwana, Masataka
    Takei, Syuji
    Tamura, Naoto
    Fujii, Takao
    Matsuno, Hiroaki
    Momohara, Shigeki
    Yamamoto, Kazuhiko
    Kokubo, Takeshi
    Endo, Yutaka
    Sugiyama, Naonobu
    Hirose, Tomohiro
    Morishima, Yosuke
    Yoshii, Noritoshi
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [5] POST-MARKETING SURVEILLANCE OF TOFACITINIB IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS: AN INTERIM REPORT OF SAFETY DATA
    Mimori, T.
    Harigai, M.
    Atsumi, T.
    Kuwana, M.
    Takei, S.
    Tamura, N.
    Fuji, T.
    Matsuno, H.
    Momohara, S.
    Yamamoto, K.
    Kokubo, T.
    Endo, Y.
    Sugiyama, N.
    Hirose, T.
    Morishima, Y.
    Yoshii, N.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1200 - 1201
  • [6] Real-world safety of nusinersen in Japan: results from an interim analysis of a post-marketing surveillance and safety database
    Wataya, Takafumi
    Takasaki, Sakura
    Hoshino, Misuzu
    Makioka, Haruki
    Nakamura, Genshu
    Matsuda, Naoto
    [J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2023, 133 (08) : 851 - 863
  • [7] SAFETY AND EFFECTIVENESS OF BEVACIZUMAB IN JAPANESE PATIENTS WITH MALIGNANT GLIOMA: POST-MARKETING SURVEILLANCE RESULTS
    Nishikawa, Ryo
    Nagane, Motoo
    Shimizu, Ayaka
    Tamura, Takashi
    Ura, Masako
    [J]. NEURO-ONCOLOGY, 2017, 19 : 8 - 8
  • [8] Safety and effectiveness of sarilumab in Japanese patients with rheumatoid arthritis refractory to previous treatments: An interim analysis of a post-marketing surveillance
    Kameda, Hideto
    Tasaka, Sadatomo
    Takahashi, Toshiya
    Suzuki, Katsuhisa
    Soeda, Naoki
    Tanaka, Yoshiya
    [J]. MODERN RHEUMATOLOGY, 2024, 34 (03) : 444 - 452
  • [9] A JAPANESE POST-MARKETING SURVEILLANCE OF REGORAFENIB IN COLORECTAL CANCER PATIENTS: INTERIM REPORT
    Satoh, Taroh
    Yamazaki, Naoya
    Takikawa, Hajime
    Ito, Hideyuki
    Ito, Yuichiro
    Sakaguchi, Toshiaki
    Yamada, Takashi
    Muro, Kei
    Sugihara, Kenichi
    [J]. ANNALS OF ONCOLOGY, 2014, 25
  • [10] Real-world safety and effectiveness of nusinersen, a treatment for spinal muscular atrophy, in 401 Japanese patients: results from an interim analysis of post-marketing surveillance
    Tachibana, Yosuke
    Takasaki, Sakura
    Hoshino, Misuzu
    Makioka, Haruki
    Jin, Mingshou
    [J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2024, 134 (02) : 153 - 162
12345